Singapore Clinical Trial: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and Tolerability of Efimosfermin Alfa in Participants With Known or Suspected F2- or F3-Stage Metabolic Dysfunction-Associated Steatohepatitis (MASH) (ZENITH-2)

Singapore, Aug. 7 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and ... Read More

Singapore Clinical Trial: A Phase 1, Randomized, Placebo-Controlled, Investigator and Participant Blinded, Single Ascending Dose and Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LY4302814 in Healthy Participants

Singapore, Aug. 7 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Randomized, Placebo-Controlled, Investigator and Participant Blinded, Single Ascending D... Read More

Singapore Clinical Trial: A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Olverembatinib Combined with Chemotherapy Versus Investigator’s Choice of TKI Combined with Chemotherapy in Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

Singapore, Aug. 7 -- The Health Sciences Authority received information related to the study titled 'A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Olverembatinib Combine... Read More

Singapore Clinical Trial: 'Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the post-operative survival of glaucoma drainage devices'

Singapore, Aug. 7 -- The Health Sciences Authority received information related to the study titled ''Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the pos... Read More

Singapore Clinical Trial: IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507) versus Platinum-based Chemotherapy in Patients with EGFR-mutated Non-small Cell Lung Cancer and Disease Progression on EGFR Tyrosine Kinase Inhibitor Therapy.

Singapore, Aug. 7 -- The Health Sciences Authority received information related to the study titled 'IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507)... Read More

Clinical Trial: Clinical Efficacy and Peripheral Ultrasound Mechanism of Trigger Point Bloodletting Therapy for Primary Trigeminal Neuralgia

U.S., Aug. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07750730) titled 'Clinical Efficacy and Peripheral Ultrasound Mechanism of Trigger Point Bloodletting Therapy ... Read More

Clinical Trial: SED Pack: Safety and Performance of a Medical Device Software for Predictive Monitoring During Sedation

U.S., Aug. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07749781) titled 'SED Pack: Safety and Performance of a Medical Device Software for Predictive Monitoring Duri... Read More

Clinical Trial: Comparison of TLIP Block and QIP Block for Postoperative Analgesia After Lumbar Spine Surgery

U.S., Aug. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07750418) titled 'Comparison of TLIP Block and QIP Block for Postoperative Analgesia After Lumbar Spine Surger... Read More

Singapore Clinical Trial: ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemotherapy Versus Bevacizumab in Combination with Chemotherapy in Participants with Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

Singapore, Aug. 7 -- The Health Sciences Authority received information related to the study titled 'ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemotherap... Read More

Clinical Trial: Comparison Between Low-Dose and High-Dose Nepafenac Sodium

U.S., Aug. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07749027) titled 'Comparison Between Low-Dose and High-Dose Nepafenac Sodium' on July 31. Brief Summary: In S... Read More

• ««
• «
• 1378
• 1379
• 1380
• 1381
• 1382
• 1383
• 1384
• 1385
• 1386
• 1387
• »
• »»